Paper Details
- Home
- Paper Details
Original Abstract of the Article :
The efficacy and safety of terazosin were compared with those of other antihypertensive drugs in three parallel-group, randomized, double-blind studies in which 133 patients with mild to moderate hypertension participated. In two studies, terazosin monotherapy was compared with placebo and prazosin ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/0002-9343(86)90851-x
データ提供:米国国立医学図書館(NLM)
Terazosine: A New Player in Hypertension Treatment
In the ever-evolving landscape of [hypertension treatment], a new contender emerged: [terazosine]. This study delves into the effectiveness and safety of this drug by comparing it to other established antihypertensive agents. The researchers enrolled 133 patients with [mild to moderate hypertension] and randomly assigned them to different treatment groups, including [terazosine monotherapy, placebo, prazosin, hydrochlorothiazide]. The study meticulously measured blood pressure changes and monitored for any adverse events. Their findings showed that [terazosin demonstrated comparable effectiveness to prazosin], and that both drugs were [well tolerated], with a similar incidence of side effects like [headache, dizziness, malaise].
Terazosine: A Promising Prospect
The study reveals that terazosin, a relative newcomer to the hypertension treatment scene, holds its own against its more seasoned counterparts. The researchers observed that [terazosine consistently lowered blood pressure] in a dose-dependent manner. The results show that a [dose of 1 to 10 mg twice daily] was well tolerated, indicating its potential for safe and effective use in managing hypertension.
Terazosine: A New Avenue for Blood Pressure Control
This study, like a desert oasis, provides valuable information for [patients and physicians] seeking effective options for [blood pressure control]. It suggests that [terazosin] can be a viable choice for patients with mild to moderate hypertension, offering comparable effectiveness and safety to existing treatments. It’s important to note that [individual responses may vary], so finding the right treatment approach requires a partnership between patient and healthcare provider.
Dr.Camel's Conclusion
This research reveals terazosin as a promising addition to the arsenal of antihypertensive drugs. Its comparable effectiveness to prazosin and favorable safety profile suggest its potential for safe and effective blood pressure control. However, individual responses to medication can vary, so it’s crucial for patients to discuss their specific needs and goals with their healthcare providers to determine the most appropriate treatment plan.
Date :
- Date Completed 1986-06-27
- Date Revised 2019-06-26
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.